Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk stock fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its ...

Doctors are seeing an increase in hair loss among Ozempic users due to the stress of rapid weight loss. The condition is ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

About 2% of U.S. adults use GLP-1 drugs, but results vary. Diet, exercise, and mental health remain key to long-term success.

Novo Nordisk stock took a big hit early Tuesday after the Danish weight-loss drugmaker unexpectedly cuts its full-year ...

The Ozempic makeover trend is sweeping the nation. Discover what it is, what experts warn, and why it’s more complicated than ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

Discover effective weight loss strategies from Snigdha Baruah, who lost 35 kg without shortcuts, Ozempic, or extreme workouts ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...